266 related articles for article (PubMed ID: 25712544)
1. Voice features of Parkinson's disease patients with subthalamic nucleus deep brain stimulation.
Tanaka Y; Tsuboi T; Watanabe H; Kajita Y; Fujimoto Y; Ohdake R; Yoneyama N; Masuda M; Hara K; Senda J; Ito M; Atsuta N; Horiguchi S; Yamamoto M; Wakabayashi T; Sobue G
J Neurol; 2015 May; 262(5):1173-81. PubMed ID: 25712544
[TBL] [Abstract][Full Text] [Related]
2. Characteristic laryngoscopic findings in Parkinson's disease patients after subthalamic nucleus deep brain stimulation and its correlation with voice disorder.
Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Yoneyama N; Hara K; Ito M; Hirayama M; Yamamoto M; Fujimoto Y; Kajita Y; Wakabayashi T; Sobue G
J Neural Transm (Vienna); 2015 Dec; 122(12):1663-72. PubMed ID: 26254905
[TBL] [Abstract][Full Text] [Related]
3. Early detection of speech and voice disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study.
Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Hattori M; Kawabata K; Hara K; Ito M; Fujimoto Y; Nakatsubo D; Maesawa S; Kajita Y; Katsuno M; Sobue G
J Neural Transm (Vienna); 2017 Dec; 124(12):1547-1556. PubMed ID: 29098450
[TBL] [Abstract][Full Text] [Related]
4. Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation.
Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Yoneyama N; Hara K; Nakamura R; Watanabe H; Senda J; Atsuta N; Ito M; Hirayama M; Yamamoto M; Fujimoto Y; Kajita Y; Wakabayashi T; Sobue G
J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):856-64. PubMed ID: 25280914
[TBL] [Abstract][Full Text] [Related]
5. Modulation of dysarthropneumophonia by low-frequency STN DBS in advanced Parkinson's disease.
Moreau C; Pennel-Ployart O; Pinto S; Plachez A; Annic A; Viallet F; Destée A; Defebvre L
Mov Disord; 2011 Mar; 26(4):659-63. PubMed ID: 21506146
[TBL] [Abstract][Full Text] [Related]
6. Articulation Features of Parkinson's Disease Patients with Subthalamic Nucleus Deep Brain Stimulation.
Tanaka Y; Tsuboi T; Watanabe H; Kajita Y; Nakatsubo D; Fujimoto Y; Ohdake R; Ito M; Atsuta N; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
J Parkinsons Dis; 2016 Oct; 6(4):811-819. PubMed ID: 27662325
[TBL] [Abstract][Full Text] [Related]
7. Intensive voice treatment (LSVT®LOUD) for Parkinson's disease following deep brain stimulation of the subthalamic nucleus.
Spielman J; Mahler L; Halpern A; Gilley P; Klepitskaya O; Ramig L
J Commun Disord; 2011; 44(6):688-700. PubMed ID: 21724193
[TBL] [Abstract][Full Text] [Related]
8. The impact of STN deep brain stimulation on speech in individuals with Parkinson's disease: the patient's perspective.
Wertheimer J; Gottuso AY; Nuno M; Walton C; Duboille A; Tuchman M; Ramig L
Parkinsonism Relat Disord; 2014 Oct; 20(10):1065-70. PubMed ID: 25048615
[TBL] [Abstract][Full Text] [Related]
9. Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson's disease.
Klostermann F; Ehlen F; Vesper J; Nubel K; Gross M; Marzinzik F; Curio G; Sappok T
J Neurol Neurosurg Psychiatry; 2008 May; 79(5):522-9. PubMed ID: 17766427
[TBL] [Abstract][Full Text] [Related]
10. Verbal Fluency in Parkinson's Patients with and without Bilateral Deep Brain Stimulation of the Subthalamic Nucleus: A Meta-analysis.
Wyman-Chick KA
J Int Neuropsychol Soc; 2016 Apr; 22(4):478-85. PubMed ID: 26831827
[TBL] [Abstract][Full Text] [Related]
11. Effects of Deep Brain Stimulation of the Subthalamic Nucleus Settings on Voice Quality, Intensity, and Prosody in Parkinson's Disease: Preliminary Evidence for Speech Optimization.
Abeyesekera A; Adams S; Mancinelli C; Knowles T; Gilmore G; Delrobaei M; Jog M
Can J Neurol Sci; 2019 May; 46(3):287-294. PubMed ID: 30905324
[TBL] [Abstract][Full Text] [Related]
12. Direct subthalamic nucleus stimulation influences speech and voice quality in Parkinson's disease patients.
Bobin M; Sulzer N; Bründler G; Staib M; Imbach LL; Stieglitz LH; Krauss P; Bichsel O; Baumann CR; Frühholz S
Brain Stimul; 2024; 17(1):112-124. PubMed ID: 38272256
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Speech Change After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease Patients: A 2-Year Prospective Study.
Tanaka Y; Tsuboi T; Watanabe H; Nakatsubo D; Maesawa S; Kato S; Kajita Y; Sato M; Oodake R; Hattori M; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
J Parkinsons Dis; 2020; 10(1):131-140. PubMed ID: 31884493
[TBL] [Abstract][Full Text] [Related]
14. Speech outcomes in Parkinson's disease after subthalamic nucleus deep brain stimulation: A systematic review.
Aldridge D; Theodoros D; Angwin A; Vogel AP
Parkinsonism Relat Disord; 2016 Dec; 33():3-11. PubMed ID: 27693195
[TBL] [Abstract][Full Text] [Related]
15. Voice Tremor Outcomes of Subthalamic Nucleus and Zona Incerta Deep Brain Stimulation in Patients With Parkinson Disease.
Karlsson F; Malinova E; Olofsson K; Blomstedt P; Linder J; Nordh E
J Voice; 2019 Jul; 33(4):545-549. PubMed ID: 29361338
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation on gait kinematics in Parkinson's disease: a randomized, blinded study.
Lizarraga KJ; Jagid JR; Luca CC
J Neurol; 2016 Aug; 263(8):1652-6. PubMed ID: 27278062
[TBL] [Abstract][Full Text] [Related]
17. Dysphonia and Dysarthria in People With Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation: Effect of Frequency Modulation.
Morello ANDC; Beber BC; Fagundes VC; Cielo CA; Rieder CRM
J Voice; 2020 May; 34(3):477-484. PubMed ID: 30454944
[TBL] [Abstract][Full Text] [Related]
18. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
[TBL] [Abstract][Full Text] [Related]
19. Verbal fluency in patients receiving bilateral versus left-sided deep brain stimulation of the subthalamic nucleus for Parkinson's disease.
Sjöberg RL; Lidman E; Häggström B; Hariz MI; Linder J; Fredricks A; Blomstedt P
J Int Neuropsychol Soc; 2012 May; 18(3):606-11. PubMed ID: 22264411
[TBL] [Abstract][Full Text] [Related]
20. Pyramidal tract activation due to subthalamic deep brain stimulation in Parkinson's disease.
Mahlknecht P; Akram H; Georgiev D; Tripoliti E; Candelario J; Zacharia A; Zrinzo L; Hyam J; Hariz M; Foltynie T; Rothwell JC; Limousin P
Mov Disord; 2017 Aug; 32(8):1174-1182. PubMed ID: 28590508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
